Through a series of experiments supported by the National Institutes of Health, Johns Hopkins Medicine (JHM) researchers say they have advanced understanding of how smoking damages the eye and ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host a free webinar for eye care professionals to explore the ...

The study assessed changes in retinal structure and visual function before and after intravitreal pegcetacoplan initiation. A ...

Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and ...

Hopkins researchers identify how smoking, a well-known risk factor for eye disease and vision loss, increases susceptibility ...

Through a series of experiments supported by the National Institutes of Health, Johns Hopkins Medicine (JHM) researchers say ...

Professor Souied is a renowned ophthalmologist and international expert in AMD (Age-related Macular Degeneration)  He will guide the scientific focus of SeaBeLife’s ophthalmological program, the only ...

Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.